A novel diagnostic target in the hepatitis C virus genome
2009

A New Test for Hepatitis C Virus Detection

Sample size: 725 publication 10 minutes Evidence: high

Author Information

Author(s): Drexler Jan Felix, Kupfer Bernd, Petersen Nadine, Grotto Rejane Maria Tommasini, Rodrigues Silvia Maria Corvino, Grywna Klaus, Panning Marcus, Annan Augustina, Silva Giovanni Faria, Douglas Jill, Koay Evelyn S. C, Smuts Heidi, Netto Eduardo M, Simmonds Peter, Pardini Maria Inês de Moura Campos, Roth W. Kurt, Drosten Christian

Primary Institution: Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany

Hypothesis

Can the 3′-X-tail element of the hepatitis C virus genome serve as a reliable diagnostic target for developing new assays?

Conclusion

The study demonstrates that a new assay based on the X-tail element can significantly improve hepatitis C virus detection and monitoring.

Supporting Evidence

  • The new assay detected low levels of HCV RNA in all genotype reference samples.
  • X-tail-based viral loads were highly concordant with established bDNA results.
  • The lower limit of detection was determined to be 18.4 IU/ml.
  • The assay was implemented successfully in a Brazilian laboratory.
  • X-tail RT-PCR showed high sensitivity and robustness across all genotypes.
  • Costs for the assay were significantly lower than existing commercial tests.
  • The study included a diverse panel of clinical specimens from multiple continents.
  • Correlation coefficients between X-tail and bDNA were high for all genotypes.

Takeaway

Researchers created a new test to find hepatitis C virus that works better and is cheaper, especially for countries that can't afford expensive tests.

Methodology

The study involved de novo sequencing of the 3′-X-tail element and evaluation of a prototype qualitative and quantitative test on 725 clinical plasma samples from various countries.

Potential Biases

Potential bias due to the selection of samples from specific geographic regions.

Limitations

The study did not assess the long-term stability of the assay in various settings.

Participant Demographics

Samples were collected from patients in Germany, UK, Brazil, South Africa, and Singapore, covering HCV genotypes 1–6.

Statistical Information

P-Value

p<0.01

Confidence Interval

15.3–24.1 IU/ml

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1371/journal.pmed.1000031

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication